chlorzoxazone

Generic: chlorzoxazone

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name chlorzoxazone
Generic Name chlorzoxazone
Labeler rising pharma holdings, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

chlorzoxazone 375 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 16571-725
Product ID 16571-725_b4a7f61d-613e-4d8f-a3fc-37143c6e19c3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213126
Listing Expiration 2026-12-31
Marketing Start 2022-04-05

Pharmacologic Class

Established (EPC)
muscle relaxant [epc]
Physiologic Effect
centrally-mediated muscle relaxation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16571725
Hyphenated Format 16571-725

Supplemental Identifiers

RxCUI
197502 1088934 1088936
UPC
0316571727018
UNII
H0DE420U8G
NUI
N0000175730 N0000175737

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name chlorzoxazone (source: ndc)
Generic Name chlorzoxazone (source: ndc)
Application Number ANDA213126 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 375 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (16571-725-01)
  • 500 TABLET in 1 BOTTLE (16571-725-50)
source: ndc

Packages (2)

Ingredients (1)

chlorzoxazone (375 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b4a7f61d-613e-4d8f-a3fc-37143c6e19c3", "openfda": {"nui": ["N0000175730", "N0000175737"], "upc": ["0316571727018"], "unii": ["H0DE420U8G"], "rxcui": ["197502", "1088934", "1088936"], "spl_set_id": ["1df6058b-7bf2-4246-9827-93fa023a5fd4"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (16571-725-01)", "package_ndc": "16571-725-01", "marketing_start_date": "20220405"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (16571-725-50)", "package_ndc": "16571-725-50", "marketing_start_date": "20220405"}], "brand_name": "CHLORZOXAZONE", "product_id": "16571-725_b4a7f61d-613e-4d8f-a3fc-37143c6e19c3", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "16571-725", "generic_name": "CHLORZOXAZONE", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CHLORZOXAZONE", "active_ingredients": [{"name": "CHLORZOXAZONE", "strength": "375 mg/1"}], "application_number": "ANDA213126", "marketing_category": "ANDA", "marketing_start_date": "20220405", "listing_expiration_date": "20261231"}